Asia’s first 14-day continuous ECG recorder

Increased Detection Rate

The pioneering 14-day continuous recording increases the detection rate of arrhythmia by 3-5 times

Increased Detection Rate

The pioneering 14-day continuous recording increases the detection rate of arrhythmia by 3-5 times

No Miss in Full Record

Nothing is missed out in continuous recording, which can detect both paroxysmal and asymptomatic arrhythmia

No Miss in Full Record

Nothing is missed out in continuous recording, which can detect both paroxysmal and asymptomatic arrhythmia

Non-Invasive Adhesion

The non-invasive, waterproof adhesion does not interfere with daily life

Non-Invasive Adhesion

The non-invasive, waterproof adhesion does not interfere with daily life

Medical Grade Certification

Certified by TFDA and CE Marking for Medical Devices. Adopted by major medical centers

Medical Grade Certification

Certified by TFDA and CE Marking for Medical Devices. Adopted by major medical centers

Increased Detection Rate

Pioneer 14-day continuous recording detects 3-5 fold arrhythmia

No Miss in Full Record

Nothing is missed out. Detect paroxysmal & asymptomatic arrhythmia

Non-Invasive Adhesion

The non-invasive, waterproof adhesion does not interfere with daily life

Medical Grade Certification

Certified by TFDA and CE Marking. Adopted by major medical centers

EZYPRO®—Asia’s first non-invasive 14-day continuous ECG recorder

The increased monitoring duration ensures a complete recording of arrhythmia symptoms and largely increases the diagnosis rate

COMPLETE RECORDING AND INCREASED DIAGNOSIS RATE

The ECG monitoring time is extended to 7-14 days, and the diagnosis rate of atrial fibrillation is increased to 3-5 times(1)(2)

Long-term heart rhythm monitoring has been incorporated into the guideline of major American and European associations:

  • AHA (American Heart Association)
  • ACC (American college of Cardiology)
  • ESC (European Society of Cardiology)
  • HRS (Heart Rhythm Society)
  • NICE (National institute for Health and Care Excellence)

Sources :
(1) : Am J Cardiol. 2013 Aug 15;112(4):520-4
(2) : N Engl J Med 2014; 370:2478-2486

Professional assistance with wearing EZYPRO®
The lightweight, slim, and waterproof recorder makes the test easy and stress-free

EZYPRO®: Lightweight and waterproof makes stress-free

Location Confirmation

EZYPRO® is attached to the left chest. The recorder is lightweight and slim, and the test is easy without a trace

Wearing

Wearing the waterproof EZYPRO® does not impair with daily life

Monitoring

Upon initiation, EZYPRO® can continuously record heart rhythm information for up to 14 days

Removal

After the test is done, EZYPRO® is removed and sent back to the hospital for analysis

Sigknow’s EZYPRO®—An accurate measurement of ECG signals

EZYPRO® is acquired by medical institutions.
The analysis report will assist doctors to diagnose and devise treatment options

EZYPRO®: acquired by medical institutions, assist doctors devise treatment plans

Symptoms & Find a Doctor

Patients with arrhythmia symptoms seek diagnosis in healthcare providers

Prescribe & Monitor

Doctors prescribe EZYPRO® and patients wear it for up to 14 days

Prescribe & Monitor

Doctors prescribe EZYPRO® and patients wear it for up to 14 days

Analyze & Diagnose

EZYPRO® return to hospitals, analyze by ECG professionals and diagnose by cardiologists

Treat & Prevent

Treatment plans based on confirmed diagnosis

Treat & Prevent

Treatment plans based on confirmed diagnosis

Copy Protected by Chetan's WP-Copyprotect.